Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
4C Medical Technologies Presents Data from the Global Clinical Experience for the AltaValve Early Feasibility Study at AATS 2022 2022-05-19 20:06
I-Mab to Hold Investor Call to Report Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab 2022-05-19 20:00
Berry Oncology Launches an Innovative Self-Iterative "HIFI" System 2022-05-19 09:00
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding 2022-05-19 04:56
OriCiro Genomics expand into Boston, Open new office in North America 2022-05-18 22:00
Laekna Therapeutics Raises $61 Million in Series D financing 2022-05-18 20:00
BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement 2022-05-18 20:00
HistoIndex Welcomes Life Sciences and MedTech Visionary, David John Jeans CBE, to Board of Directors 2022-05-18 19:00
DelSiTech and Anticancer Bioscience Announce a Collaboration Agreement for the Development of Long-acting Therapies in Oncology 2022-05-18 16:00
Antengene Announces XPOVIO® Treatment Regimens Included for the First Time in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China 2022-05-18 15:01
KAZIA MARKS DIPG AWARENESS DAY; NEW PRECLINICAL DATA IN DIPG TO BE PRESENTED AT ISPNO CONFERENCE 2022-05-17 20:00
ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY 2022-05-17 15:00
Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China 2022-05-16 11:20
Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system 2022-05-16 10:00
GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia 2022-05-16 09:00
Kintor Pharma Included in MSCI China Index 2022-05-15 18:28
Dizal Announces New Data from the Phase I/II Study of Golidocitnib in Refractory or Relapsed Peripheral T Cell Lymphoma Selected for Oral Presentation at 2022 EHA Annual Meeting 2022-05-13 19:09
Antengene Announces XPOVIO® (selinexor) Data to be Presented at the Upcoming 2022 European Hematology Association Hybrid Congress 2022-05-13 18:00
Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines 2022-05-13 08:30
Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria 2022-05-12 22:43
1 138 139 140 141 142 415